Professor, Department of Psychiatry and Behavioral Sciences, University of Miami, United States. Former, Director General of the Italian Medicines Agency (AIFA); Former CHMP and SAWP, European Medicines Agency (EMA), London.
Luca Pani is an internationally recognized expert in pharmacology and advancement in regulatory science with particular emphasis on health technology assessment linked to novel negotiation strategies for the registration and reimbursement of precision medicines. In his past roles, he has been the lead negotiator for the first world gene-therapy, and he has designed new management entry agreements scheme by the use of web-based certified real-life registries for evaluating drug effectiveness.
He is the author of over 160 scientific publications, editor and author of several volumes among which the highly downloaded book "Sustainable Innovation: Medicines and the Challenges for the Future of our National Health Service.”